MicroRNAs in autoimmune rheumatic diseases

被引:3
|
作者
Galeazzi, M. [1 ]
Balistreri, E. [1 ]
Giannitti, C. [1 ]
Sebastiani, G. D. [2 ]
机构
[1] Univ Siena, UOC Reumatol, Dipartimento Med Clin & Sci Immunol, Siena, Italy
[2] UOC Reumatol, Azienda Osped San Camillo Forlanini, Circonvallaz Gianicolense 87, I-00152 Rome, Italy
关键词
Autoimmune diseases; epigenetics; microRNAs;
D O I
10.4081/reumatismo.2012.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology of autoimmune diseases remains largely unknown. In recent years, besides genetic factors, several studies proposed that the epigenome might hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically epigenetic regulatory mechanisms comprise DNA methylation, a variety of histone modifications, and microRNA (miRNA) activity, all of which act upon gene and protein expression levels. In particular, it is well known that epigenetic mechanisms are important for controlling the pattern of gene expression during development, the cell cycle, and the response to biological or environmental changes. In the present review a description of the most frequent epigenetic deregulations, in particular the role of miRNAs, in rheumatic autoimmune disorders will be investigated.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 50 条
  • [41] THE ENDOCRINE ASSOCIATIONS OF THE AUTOIMMUNE RHEUMATIC DISEASES
    GORDON, T
    ISENBERG, D
    BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 : 15 - 15
  • [42] THE ENDOCRINOLOGIC ASSOCIATIONS OF THE AUTOIMMUNE RHEUMATIC DISEASES
    GORDON, T
    ISENBERG, D
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1987, 17 (01) : 58 - 70
  • [43] The Impact of Menopause on Autoimmune and Rheumatic Diseases
    Francesca Motta
    Nicoletta Di Simone
    Carlo Selmi
    Clinical Reviews in Allergy & Immunology, 68 (1)
  • [44] Oxidative stress in autoimmune rheumatic diseases
    Smallwood, Miranda J.
    Nissim, Ahuva
    Knight, Annie R.
    Whiteman, Matthew
    Haigh, Richard
    Winyard, Paul G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 125 : 3 - 14
  • [45] Canakinumab in autoimmune and autoinflammatory rheumatic diseases
    Kadavath, Sabeeda
    Efthimiou, Petros
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (01): : 27 - 35
  • [46] Cognitive dysfunction in autoimmune rheumatic diseases
    Olah, Csaba
    Schwartz, Noa
    Denton, Christopher
    Kardos, Zsofia
    Putterman, Chaim
    Szekanecz, Zoltan
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [47] Hormonal treatment in autoimmune rheumatic diseases
    Jara-Quezada, L. J.
    Mora-Trujillo, C. S.
    Vera-Lastra, O. L.
    Saavedra-Salinas, M. A.
    REUMATOLOGIA CLINICA, 2005, 1 : S59 - S69
  • [48] Cell therapy in rheumatic Autoimmune diseases
    Hiepe, F.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 : S14 - S15
  • [49] Cardiovascular Consequences of Autoimmune Rheumatic Diseases
    Atzeni, Fabiola
    Nucera, Valeria
    Gerratana, Elisabetta
    Fiorenza, Alessia
    Gianturco, Luigi
    Corda, Marco
    Sarzi-Puttini, Piercarlo
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (06) : 566 - 579
  • [50] Tobacco smoking and autoimmune rheumatic diseases
    Harel-Meir, Michal
    Sherer, Yaniv
    Shoenfeld, Yehuda
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (12): : 707 - 715